Molecular physiology of renal ClC chloride channels/transporters

Current Opinion in Nephrology and Hypertension

Volumn 15, Issue 5, 2006, Pages 511-516

  Sile, Saba ^a   Vanoye, Carlos G ^a   George Jr , Alfred L ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Genetic Medicine   (United States)

Author keywords

Bartter syndrome; Chloride channel; Hypertension; Ion transporter; Polymorphism

Indexed keywords

FUROSEMIDE; PROTEIN NKCC1; PROTEIN NKCC2; PROTEIN OSR1; PROTEIN SERINE THREONINE KINASE; PROTEIN SPAK; PROTEIN WNK; RENIN; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; UNCLASSIFIED DRUG;

BLOOD PRESSURE REGULATION; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; HYPERTENSION; MACROMOLECULE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REGULATORY MECHANISM; REVIEW; RNA SPLICING;

ANIMALS; CHLORIDE CHANNELS; CYSTATHIONINE BETA-SYNTHASE; ENDOSOMES; HUMANS; KIDNEY; PERMEABILITY; PROTEIN STRUCTURE, TERTIARY;

EID: 33747361255     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mnh.0000242177.36953.be     Document Type: Review

References (54)

1. Miller C. ClC chloride channels viewed through a transporter lens. Nature 2006; 440:484-489. This is a superb and elegant review of newly recognized transporter behaviors of ClC proteins with emphasis on structural determinants of permeation.
2. - channels. Nature 2004; 427:803-807.
3. - channels. This observation raises questions about the proposed mechanism for role of ClC-5 in providing a shunt conductance in endosomes.
4. + exchangers, and further examined proton transport in other ClC proteins.
5. Friedrich T, Breiderhoff T, Jentsch TJ. Mutational analysis demonstrates that ClC-4 and ClC-5 directly mediate plasma membrane currents. J Biol Chem 1999; 274:896-902.
6. Vanoye CG, George AL Jr. Functional characterization of recombinant human ClC-4 chloride channels in cultured mammalian cells. J Physiol (London) 2002; 539:373-383.
7. Lobet S, Dutzler R. Ion-binding properties of the ClC chloride selectivity filter. EMBO J 2006; 25:24-33. This is an x-ray crystallographic study delineating chloride ion binding sites within the bacterial ClCec-1 protein.
8. Waldegger S, Jentsch TJ. Functional and structural analysis of ClC-K chloride channels involved in renal disease. J Biol Chem 2000; 275:24527-24533.
9. Engh AM, Maduke M. Cysteine accessibility in ClC-0 supports conservation of the ClC intracellular vestibule. J Gen Physiol 2005; 125:601-617.
10. + transport in bacterial ClCec-1. These observations provide valuable insight into the structural/ functional differences between ClC channels and transporters.
11. Denton J, Nehrke K, Yin X, et al. Altered gating and regulation of a carboxy-terminal ClC channel mutant expressed in the Caenorhabditis elegans oocyte. Am J Physiol Cell Physiol 2006; 290:C1109-C1118.
12. He L, Denton J, Nehrke K. Carboxy terminus splice variation alters ClC channel gating and extracellular cysteine reactivity. Biophys J 2006; 90:3570-3581.
13. Hebeisen S, Fahlke C. Carboxy-terminal truncations modify the outer pore vestibule of muscle chloride channels. Biophys J 2005; 3:1710-1720.
14. Schmidt-Rose T, Jentsch TJ. Reconstitution of functional voltage-gated chloride channels from complementary fragments of CLC-1. J Biol Chem 1997; 272:20515-20521.
15. Maduke M, Williams C, Miller C. Formation of CLC-0 chloride channels from separated transmembrane and cytoplasmic domains. Biochemistry 1998; 37:1315-1321.
16. 2 and COOH terminus of the yeast CLC putative chloride channel Gef1p. J Biol Chem 1998; 273:15110-15118.
17. Carr G, Simmons N, Sayer J. A role for CBS domain 2 in trafficking of chloride channel CLC-5. Biochem Biophys Res Commun 2003; 310:600-605.
18. Hebeisen S, Biela A, Giese B, et al. The role of the carboxy-terminus in ClC chloride channel function. J Biol Chem 2004; 279:13140-13147.
19. Estevez R, Pusch M, Ferrer-Costa C, et al. Functional and structural conservation of CBS domains from CLC chloride channels. J Physiol (London) 2004; 557:363-378.
20. Scott JW, Hawley SA, Green KA, et al. CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. J Clin Invest 2004; 113:274-284.
21. Bennetts B, Rychkov GY, Ng HL, et al. Cytoplasmic ATP-sensing domains regulate gating of skeletal muscle ClC-1 chloride channels. J Biol Chem 2005; 280:32452-32458.
22. Niemeyer MI, Yusef YR, Cornejo I, et al. Functional evaluation of human ClC-2 chloride channel mutations associated with idiopathic generalized epilepsies. Physiol Genomics 2004; 19:74-83.
23. Meyer S, Dutzler R. Crystal structure of the cytoplasmic domain of the chloride channel ClC-0. Structure 2006; 14:299-307. This is an x-ray crystallographic study defining a high resolution structure for the carboxyl-terminus of the eukaryotic ClC-0 purified from T. marmorata with emphasis on the CBS subdomains.
24. Yusef YR, Zuniga L, Catalan M, et al. Removal of gating in voltage-dependent ClC-2 chloride channel by point mutations affecting the pore and C-terminus CBS-2 domain. J Physiol 2006; 572:173-181.
25. Hara-Chikuma M, Wang YH, Guggino SE, et al. Impaired acidification in early endosomes of CIC-5 deficient proximal tubule. Biochem Biophys Res Commun 2005; 329:941-946.
26. Lange PF, Wartosch L, Jentsch TJ, et al. ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function. Nature 2006; 440:220-223.
27. Debigare R, Price SR. Proteolysis, the ubiquitin-proteasome system, and renal diseases. Am J Physiol Renal Physiol 2003; 285:F1-F8.
28. + channel by Nedd4 and ubiquitination. Kidney Int 2000; 57:809-815.
29. - channel mutated in Dent's disease. J Biol Chem 2001; 276:12049-12054.
30. Hryciw DH, Ekberg J, Lee A, et al. Nedd4-2 functionally interacts with ClC-5 - Involvement in constitutive albumin endocytosis in proximal tubule cells. J Biol Chem 2004; 279:54996-55007.
31. Embark HM, Bohmer C, Palmada M, et al. Regulation of CLC-Ka/barttin by the ubiquitin ligase Nedd4-2 and the serum- and glucocorticoid-dependent kinases. Kidney Int 2004; 66:1918-1925.
32. + transport regulation in distal kidney nephron cells. Cell Physiol Biochem 2003; 13:21-28.
33. Lifton RP, Wilson FH, Choate KA, et al. Salt and blood pressure: new insight from human genetic studies. Cold Spring Harb Symp Quant Biol 2002; 67:445-450.
34. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104:545-556.
35. + secretion. Nature 2001; 414:558-561.
36. Simon DB, Bindra RS, Mansfield TA, et al. Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nature Genet 1997; 17:171-178.
37. Birkenhager R, Otto E, Schurmann MJ, et al. Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nature Genet 2001; 29:310-314.
38. Schlingmann KP, Konrad M, Jeck N, et al. Salt wasting and deafness resulting from mutations in two chloride channels. N Engl J Med 2004; 350:1314-1319.
39. Jeck N, Waldegger P, Doroszewicz J, et al. A common sequence variation of the CLCNKB gene strongly activates ClC-Kb chloride channel activity. Kidney Int 2004; 65:190-197.
40. Jeck N, Waldegger S, Lampert A, et al. Activating mutation of the renal epithelial chloride channel ClC-Kb predisposing to hypertension. Hypertension 2004; 43:1175-1181.
41. Kokubo Y, Iwai N, Tago N, et al. Association analysis between hypertension and CYBA, CLCNKB, and KCNMB1 functional polymorphisms in the Japanese population-the Suita Study. Circ J 2005; 69:138-142.
42. Frey A, Lampert A, Waldegger S, et al. Influence of gain of function epithelial chloride channel ClC-Kb mutation on hearing thresholds. Hear Res 2006; 214:68-75.
43. Sile S, Vanoye CG, Byre LM, et al. Functional characterization of BSND variants. J Am Soc Nephrol 2005; 16:367A.
44. Matsumura Y, Uchida S, Kondo Y, et al. Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel. Nature Genet 1999; 21:95-98.
45. Picollo A, Liantonio A, Didonna MP, et al. Molecular determinants of differential pore blocking of kidney CLC-K chloride channels. EMBO Rep 2004; 5:584-589.
46. Liantonio A, Pusch M, Picollo A, et al. Investigations of pharmacologic properties of the renal CLC-K1 chloride channel co-expressed with barttin by the use of 2-(p-Chlorophenoxy)propionic acid derivatives and other structurally unrelated chloride channels blockers. J Am Soc Nephrol 2004; 15:13-20.
47. Liantonio A, Picollo A, Babini E, et al. Activation and inhibition of kidney CLC-K chloride channels by fenamates. Mol Pharmacol 2006; 69:165-173.
48. Obermuller N, Gretz N, Kriz W, et al. The swelling-activated chloride channel ClC-2, the chloride channel ClC-3, and ClC-5, a chloride channel mutated in kidney stone disease, are expressed in distinct subpopulations of renal epithelial cells. J Clin Invest 1998; 101:635-642.
49. Uchida S, Sasaki S, Nitta K, et al. Localization and functional characterization of rat kidney-specific chloride channel, ClC-K1. J Clin Invest 1995; 95:104-113.
50. Yoshikawa M, Uchida S, Yamauchi A, et al. Localization of rat CLC-K2 chloride channel mRNA in the kidney. Am J Physiol 1999; 276:F552-F558.
51. Kobayashi K, Uchida S, Mizutani S, et al. Intrarenal and cellular localization of CLC-K2 protein in the mouse kidney. J Am Soc Nephrol 2001; 12:1327-1334.
52. Mohammad-Panah R, Harrison R, Dhani S, et al. The chloride channel ClC-4 contributes to endosomal acidification and trafficking. J Biol Chem 2003; 278:29267-29277.
53. Devuyst O, Christie PT, Courtoy PJ, et al. Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent's disease. Hum Mol Genet 1999; 8:247-257.
54. Kida Y, Uchida S, Miyazaki H, et al. Localization of mouse CLC-6 and CLC-7 mRNA and their functional complementation of yeast CLC gene mutant. Histochem Cell Biol 2001; 115:189-194.